Bencyclan: a new drug with unusual membrane stabilising properties in erythrocytes. 1978

H C Kinsella, and S P Smith, and R G Spector

Bencyclan, a drug recently introduced to treat peripheral circulatory disease, has been shown to stabilise human erythrocytes in hypotonic saline. Two peaks of maximum stabilisation are present: at 10(-5)--10(-4) M and at 10(-3) M drug concentration.

UI MeSH Term Description Entries
D007038 Hypotonic Solutions Solutions that have a lesser osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid. Solutions, Hypotonic
D009996 Osmotic Fragility RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst. Saline Fragility,Fragility, Osmotic,Fragility, Saline
D003508 Cycloheptanes Seven-carbon cycloparaffin cycloheptane (the structural formula (CH2)7) and its derivatives.
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001537 Bencyclane A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels. Bencyclane Fumarate,Desoblit,Dilangio compositu,Fludilat,Fluxema,Halidor,Fumarate, Bencyclane,compositu, Dilangio
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

H C Kinsella, and S P Smith, and R G Spector
April 1974, Annals of clinical research,
H C Kinsella, and S P Smith, and R G Spector
February 1993, Biochemical and biophysical research communications,
H C Kinsella, and S P Smith, and R G Spector
January 1978, Progress in neuro-psychopharmacology,
H C Kinsella, and S P Smith, and R G Spector
July 1991, European journal of pharmacology,
H C Kinsella, and S P Smith, and R G Spector
July 1963, Nature,
H C Kinsella, and S P Smith, and R G Spector
January 1958, American heart journal,
H C Kinsella, and S P Smith, and R G Spector
September 1986, Lancet (London, England),
H C Kinsella, and S P Smith, and R G Spector
October 1986, Lancet (London, England),
H C Kinsella, and S P Smith, and R G Spector
January 1994, Experimental hematology,
H C Kinsella, and S P Smith, and R G Spector
June 1968, Experientia,
Copied contents to your clipboard!